Workers at Medline Industries are diligently assembling Personal Protective Equipment (PPE) kits designed for healthcare settings, particularly for those treating patients with the Ebola virus. This operation took place at their warehouse in Mundelein, Illinois, U.S., on Monday, October 20, 2014. Each PPE kit typically contains essential items such as a hooded body suit, face shield, boot covers, mask, gloves, Epi-clenz hand sanitizer, and a biohazard bag.
© 2014 Bloomberg Finance LP
Medline Industries, recognized as one of the largest producers of personal protective equipment globally, is reportedly contemplating an initial public offering (IPO) as soon as this fall, according to various sources.
With annual sales exceeding $23 billion, Medline has experienced remarkable growth for over fifty years, attributed largely to the Mills family and its recent private equity partners. Bloomberg News was the first to highlight the potential IPO, which is estimated to raise approximately $5 billion.
In 2021, a consortium of significant private equity firms, including Blackstone, Carlyle, and Hellman & Friedman, acquired a majority stake in the family-owned Medline. The company notably surged in production of personal protective equipment amidst the COVID-19 pandemic. Medline’s revenue surpassed $21 billion in sales in 2021, in part due to the addition of over 230 new healthcare provider and health system accounts, contributing nearly $2 billion in sales during the height of the pandemic, as reported by the company.
Established in 1966 and headquartered in Northfield, a suburb of northern Chicago, Medline has maintained an impressive trajectory of continuous sales growth over six decades. With a workforce of 43,000 employees worldwide, Medline’s sales have now surpassed $23 billion annually. The company’s product line is extensive, encompassing everything from masks and surgical gowns to sanitizing products and biohazard bags.
